Skip to main content
Caplight Logo









Signos

Signos

Private
Palo Alto, CaliforniaHealthcare & Life Scienceshttps://www.signos.com/

Last Round

VC Round

May 27, 2026

Total Funding Raised

$41M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Signos is a digital health company that provides an AI-driven weight management platform that integrates real-time continuous glucose monitoring data to offer personalized dietary and lifestyle recommendations.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Health IoT, D2C Brands, Subscription Commerce

Business Model

B2C

Customer Profile

Hardware + Subscription

AI Layer

Application

Keywords

continuous glucose monitoringCGMweight managementmetabolic healthCGM for weight lossFDA-cleared appmetabolic trackingover-the-counter systemOTCAI health coachpersonalized recommendationsdirect-to-consumerwearable biosensorsubscription modelDexcom Steloemployer health program

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Signos Comparables

Compare Signos with similar companies based on industry and business-model similarity.

Signos comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Levels
92%
January AI
81%
ZOE
79%

Signos Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundMay 27, 2026
Series BOct 24, 2023
Series ANov 10, 2021
SeedJan 1, 2021
SeedDec 1, 2020

Key People

Founding team and executive leadership

Sharam Fouladgar-Mercer

Co-Founder and CEO

Founding Team

Roger Neel

Chief Technology Officer

Executive Team

Signos Investors

Notable investors and investment history

Signos investors
InvestorRounds
GVVC Round, Series B, Series A
Dexcom VenturesSeries B
Courtside VenturesSeed, Series A
Samsung NEXT VenturesSeries B
Samsung Next TLVSeries B
Tau VenturesSeed, Series A
Cheyenne VenturesSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 71% MoM, reaching 135.2K.

  • May 27, 2026

    $20M raised with participation from GV and DexCom.

Signos Filings

Explore SEC and related filing metadata, where available.

Signos filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Signos's valuation, stock price, and market status.

Is Signos a public or private company?

Signos is a private company.

What is the current stock price of Signos?

Signos is a private company with no public stock price. No recent secondary market data is available.

How much is Signos worth (valuation)?

Valuation information for Signos is not publicly available.

Can I buy Signos stock?

Signos shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Signos's last funding round?

Signos's most recent funding round was Early Funding on May 27, 2026.

Who are the main investors in Signos?

Key investors in Signos include GV, Courtside Ventures, Cheyenne Ventures.

Will Signos IPO soon?

No public IPO plans have been announced for Signos.

How can I track Signos secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Signos's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersPalo Alto, California
Employee Range51
Year Founded2018
Last FundingMay 27, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?